Pharmaceuticals

Infographics_Therapeutic_Plasma_Exchange_Market_1.jpg

Therapeutic Plasma Exchange Market Size, Share & Trends Analysis Report By Product & Technologies (Product (Consumables & Devices) And Technology (Centrifugation & Membrane Separation)), By Indication, By End-Users, Region And Segment Forecasts, 2025-2034

Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034. Plasma exchange is a biological procedure that removes large-molecular-weight substances such as harmful antibodies from the plasma. I...

Slide2-min_(6)43.JPG

Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Other Antimicrobials and Antibiotics, By Mode Of Delivery, By Animal Type, Region And Segment Forecasts, 2025-2034

Veterinary Antibiotics Market Size is valued at USD 4.99 Billion in 2024 and is predicted to reach USD 6.95 Billion by the year 2034 at a 3.5 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: ...

sldd6.JPG

Biosimilar Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Product (Infliximab, Trastuzumab, Rituximab, Adalimumab, Bevacizumab, Cetuximab, Ranibizumab, Denosumab, Eculizumab, Other Pipeline Products), By Indication, By Region, And Segment Forecasts, 2025-2034

Global Biosimilar Monoclonal Antibodies Market Size is valued at USD 7.8 Billion in 2024 and is predicted to reach USD 32.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from ...

Main44.JPG

Real World Evidence (RWE) Oncology Market Size, Share & Trends Analysis Report By Component (Real-world Datasets, RWE Consulting & Analytics Services), Application (Drug Development & Approvals, Market Access, Post-market Surveillance), End User, By Region, And By Segment Forecasts, 2025-2034.

Global Real World Evidence (RWE) Oncology Market size is valued at USD 772.5 Mn in 2024 and is predicted to reach USD 2,373.9 Mn by the year 2034 at a 12.1% CAGR during the forecast period for 2025-2034. Real-world evidence (RWE) is the term used in...

sslld.JPG

Cancer Biosimilars Market Size, Share & Trends Analysis Report By Type (Lung Cancer, Breast cancer, Ovarian cancer, Prostate cancer, Lymphoma, Others), By Distribution Channel, By Drug Class, By Route of Administration, Region And Segment Forecasts, 2023-2031

The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031.   Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical simil...

slid83.JPG

Adalimumab Biosimilar Market Size, Share & Trends Analysis Report By Product (Amjevita, Cyltezo, Hadlima, Yusimry, Hulio, Hymiroz, Abrilada, Yuflyma, Exemptia, Adalirel, Cipleumab and other pipeline products), By Application, By Distribution Channel, By Region, And By Segment Forecasts, 2025-2034

Global Adalimumab Biosimilar Market Size is estimated to grow at the CAGR of 23.0% during the forecast period for 2025-2034. Adalimumab is a human monoclonal antibody that inhibits tumor necrosis factor (TNF), which is a soluble inflammatory cy...

slld50.JPG

Etanercept Biosimilar Market Size, Share & Trends Analysis Report By Applications (Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, And Ankylosing Spondylitis), Distribution Channel, Region And Segment Forecasts, 2025-2034.

The Etanercept Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an 17.8% CAGR during the forecast period for 2025-2034. Etanercept is a tumor necrosis factor alpha (TNF-&alph...